SOX9 reprograms endothelial cells by altering the chromatin landscape

The transcription factor SOX9 is activated at the onset of endothelial-to-mesenchymal transition (EndMT) during embryonic development and in pathological conditions. Its roles in regulating these processes, however, are not clear. Using human umbilical vein endothelial cells (HUVECs) as an EndMT mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuglerud, Bettina M, Drissler, Sibyl, Lotto, Jeremy, Stephan, Tabea L, Thakur, Avinash, Cullum, Rebecca, Hoodless, Pamela A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Gene regulation, Chromatin and Epigenetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410909/
https://www.ncbi.nlm.nih.gov/pubmed/35904801
http://dx.doi.org/10.1093/nar/gkac652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410909/
https://www.ncbi.nlm.nih.gov/pubmed/35904801
http://dx.doi.org/10.1093/nar/gkac652

Ejemplares similares